{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:35:48Z","timestamp":1762497348947,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":527,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.4158\/accr-2018-0429","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T16:49:11Z","timestamp":1544460551000},"page":"e192-e196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ectopic Adrenocorticotropic Hormone Syndrome Due to Metastatic Prostate Cancer With Neuroendocrine Differentiation"],"prefix":"10.1016","volume":"5","author":[{"given":"Malini","family":"Soundarrajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Zelada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Victoria","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2018-0429_bb0010","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2018-0429_bb0015","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1590\/S0004-27302007000800007","article-title":"Ectopic ACTH syndrome","volume":"51","author":"Isidori","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/ACCR-2018-0429_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2018-0429_bb0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11102-008-0100-z","article-title":"Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma","volume":"12","author":"Alwani","year":"2009","journal-title":"Pituitary"},{"key":"10.4158\/ACCR-2018-0429_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4158\/EP09243.CR","article-title":"Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer","volume":"16","author":"Alshaikh","year":"2010","journal-title":"Endocr Pract"},{"key":"10.4158\/ACCR-2018-0429_bb0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/iju.13225","article-title":"Treatment-related neuroendocrine prostate cancer resulting in Cushing's syndrome","volume":"23","author":"Ramalingam","year":"2016","journal-title":"Int J Urol"},{"key":"10.4158\/ACCR-2018-0429_bb0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0272-6386(01)80134-7","article-title":"Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma","volume":"37","author":"Rickman","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.4158\/ACCR-2018-0429_bb0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1097-0142(19840915)54:6<1043::AID-CNCR2820540619>3.0.CO;2-U","article-title":"Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature","volume":"54","author":"Ghali","year":"1984","journal-title":"Cancer"},{"key":"10.4158\/ACCR-2018-0429_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/imj.13063","article-title":"Ectopic Cushing syndrome due to neuroendocrine prostatic cancer","volume":"46","author":"Shrosbree","year":"2016","journal-title":"Intern Med J"},{"key":"10.4158\/ACCR-2018-0429_bb0055","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1530\/EC-17-0081","article-title":"Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature","volume":"6","author":"Elston","year":"2017","journal-title":"Endocr Connect"},{"key":"10.4158\/ACCR-2018-0429_bb0060","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.clgc.2018.09.002","article-title":"Paraneoplastic syndrome secondary to treatment emergent neuroendocrine tumor in metastatic castration-resistant prostate cancer: a unique case","volume":"17","author":"Murphy","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.4158\/ACCR-2018-0429_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrurol.2014.21","article-title":"Small cell carcinoma of the prostate","volume":"11","author":"Nadal","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.4158\/ACCR-2018-0429_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2015.00090","article-title":"Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure","volume":"5","author":"Hu","year":"2015","journal-title":"Front Oncol"},{"key":"10.4158\/ACCR-2018-0429_bb0075","first-page":"3617","article-title":"11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome","volume":"80","author":"Stewart","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2018-0429_bb0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/pros.20434","article-title":"Immunohistochemical characterization of neuroendocrine cells in prostate cancer","volume":"66","author":"Huang","year":"2006","journal-title":"Prostate"},{"key":"10.4158\/ACCR-2018-0429_bb0085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eururo.2003.11.032","article-title":"Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy","volume":"45","author":"Hirano","year":"2004","journal-title":"Eur Urol"},{"key":"10.4158\/ACCR-2018-0429_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/pros.10133","article-title":"Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma","volume":"53","author":"Fixemer","year":"2002","journal-title":"Prostate"},{"key":"10.4158\/ACCR-2018-0429_bb0095","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2018-0429_bb0100","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520303977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520303977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:30:53Z","timestamp":1762497053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520303977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2376060520303977"],"URL":"https:\/\/doi.org\/10.4158\/accr-2018-0429","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectopic Adrenocorticotropic Hormone Syndrome Due to Metastatic Prostate Cancer With Neuroendocrine Differentiation","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2018-0429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}